Abbott Global Point of Care

Waukegan, United States Founded: 1900 • Age: 126 yrs Listed
Rapid diagnostics products and solutions for point-of-care testing are provided.

About Abbott Global Point of Care

Abbott Global Point of Care is a publicly listed company based in Waukegan (United States) founded in 1900. Rapid diagnostics products and solutions for point-of-care testing are provided. The company has 2 employees. Abbott Global Point of Care has completed 12 acquisitions, including Binax, CanAm Care and Cholestech. Its website globalpointofcare.abbott draws about 622 thousand monthly visits. Abbott Global Point of Care offers products and services including i-STAT CHEM8+ Cartridge, CHOLESTECH LDXâ„¢ Analyzer, Afinionâ„¢ 2, and Panbioâ„¢ COVID-19 Antigen Self-Test. Its focus areas include Diversified Medical Devices. Its legal entity is Abbott Rapid Diagnostics A/S.

Company details

Abbott Point of Care was founded in 1900 and is headquartered in Waukegan, United States. Operations focus on the medical diagnostics sector, with products developed for point-of-care testing worldwide. Services include COVID-19 antigen self-tests, glycated hemoglobin monitoring for diabetes management, and detection tools for infectious diseases. The companys domain supports global access to these diagnostic solutions.

Key Metrics
  • Annual Revenue
    $2.36 B (USD)
    -4
    as on Dec 31, 2016
  • Net Profit
    $151.18 M (USD)
    -26
    as on Dec 31, 2016
  • EBITDA
    $119.53 M (USD)
    -8
    as on Dec 31, 2016
  • Latest Funding Round
    $37.76M (USD), Grant

    Feb 2021

  • Investors
  • Employee Count
    2
  • Investments & Acquisitions
    Binax

    & 11 more

Products & Services of Abbott Global Point of Care

Abbott Global Point of Care offers a comprehensive portfolio of products and services, including i-STAT CHEM8+ Cartridge, CHOLESTECH LDX™ Analyzer, Afinion™ 2, and Panbio™ COVID-19 Antigen Self-Test.

i-STAT CHEM8+ Cartridge
Diagnostic Cartridge

Delivers rapid blood chemistry and hematology results.

CHOLESTECH LDX™ Analyzer
Lipid Analyzer

Provides lipid profile and glucose testing quickly.

Afinion™ 2
Multi-assay Analyzer

Enables near-patient testing for various diagnostics.

Panbio™ COVID-19 Antigen Self-Test
Infectious Disease Test

Detects COVID-19 and influenza from a single swab.

Funding Insights of Abbott Global Point of Care

  • Total Rounds 3
  • Last Round Grant — $37.76M
  • First Round $21M

    (Jun 2000)

  • Investors Count 1

All 3 funding rounds of Abbott Global Point of Care with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2021$37.76MGrant––
Aug 2005Seed––
–
Jun 2000$21MDebt – Conventional––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Abbott Global Point of Care

Abbott Global Point of Care has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Abbott Global Point of Care

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Abbott Global Point of Care

Abbott Global Point of Care has strategically engaged in corporate development activities, having acquired 12 companies. Notable acquisitions include Binax, CanAm Care and Cholestech.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Drug research and development services are provided to biopharma firms.
concateno.comWynnum, Australia2015Jun 2009••••
Healthcare services are provided since 1995 in the United States.
matria.comMarietta, United States1995May 2008••••
Healthcare solutions are delivered in the United States.
paradigmhealth.comUpper Saddle River, United States1996Nov 2007$230M
Rapid Point-of-Care Coagulation analyzer
hemosense.comSan Jose, United States1997Nov 2007••••
Protein-based point-of-care tests for biomarker detection are developed.
matritech.comNewton, United States1996Aug 2007$36M
Point-of-care diagnostics solutions for chronic diseases
cholestech.comSan Diego, United States1988Jun 2007$326.3M
Immunodiagnostic testing kits are manufactured for medical diagnostics.
panbio.com.auBrisbane, Australia0Jan 2007$37M
Develops, manufactures, and markets in vitro diagnostic tests for detecting cardiac ischemia.
ischemia.comWaltham, United States1997Feb 2005$22.4M
POC products for infectious disease
binax.comPortland, United States1986Feb 2005$43M
Developer of products for the management of osteoporosis
ostex.comSeattle, United States2003Sep 2002••••
Premium access

Complete acquisition details for Abbott Global Point of Care

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Abbott Global Point of Care

14 dated milestones of Abbott Global Point of Care across 121 years, from founding to its latest funding, stage changes and deals.

  1. Founded Abbott Global Point of Care is founded.
  2. Funding First funding round of $21.0M.
  3. Acquisition Acquires Ostex International.
  4. Acquisition Acquires Binax.
  5. Acquisition Acquires Ischemia Technologies.
  6. Acquisition Acquires Panbio.
  7. Acquisition Acquires Cholestech.
  8. Acquisition Acquires Matritech.
  9. Acquisition Acquires HemoSense.
  10. IPO Lists on the stock exchange (IPO).
  11. Acquisition Acquires ParadigmHealth.
  12. Acquisition Acquires Matria Healthcare.
  13. Acquisition Acquires Concateno.
  14. Funding Latest funding round, Grant, of $37.8M.

Web traffic of Abbott Global Point of Care

The website of Abbott Global Point of Care (globalpointofcare.abbott) receives about 622.2K visits a month and ranks #198,021 among all websites worldwide, #6,410 in Health.

  • Monthly visits
    622.2K

    ▲ 148.3% vs previous month

  • Unique visitors
    119.3K

    per month

  • Global rank
    #198,021

    among all websites

  • Category rank
    #6,410

    Health · Health

Similar websites

Websites whose visitors overlap most with Abbott Global Point of Care. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
corelaboratory.abbott
corelaboratory.abbott
100%
#459,476–
citymd.com
91%
328K#168,173View details
abbott.com
87%
917.2K#65,577View details
compunetlab.com
compunetlab.com
83%
#763,235–
meinarztbedarf.com
meinarztbedarf.com
83%
#438,906–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Abbott Global Point of Care

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Diversified Medical Devices

3 companies that operate in the same segment as Abbott Global Point of Care (Diversified Medical Devices) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medical equipment for treating over 30 chronic diseases is developed.
1949Minneapolis, Minnesota, United StatesUSD 36.36 B95,000
Wide range of medical devices
1979Marlborough, Massachusetts, United StatesUSD 20.07 B53,000
Healthcare solutions are provided by Johnson & Johnson globally.
1886New Brunswick, New Jersey, United StatesUSD 94.18 B139,800
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Abbott Global Point Of Care

Premium access

Complete news archive for Abbott Global Point of Care

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abbott Global Point of Care

Abbott Global Point of Care was founded in 1900 and raised its 1st funding round 100 years after it was founded.

Abbott Global Point of Care is headquartered in Waukegan, United States. It is registered at Waukegan, Illinois, United States.

Abbott Global Point of Care has 2 employees.

Annual revenue of Abbott Global Point of Care is $2.36B as on Dec 31, 2016.

Abbott Point of Care was founded in 1900 and is headquartered in Waukegan, United States. Operations focus on the medical diagnostics sector, with products developed for point-of-care testing worldwide. Services include COVID-19 antigen self-tests, glycated hemoglobin monitoring for diabetes management, and detection tools for infectious diseases. The companys domain supports global access to these diagnostic solutions.

Abbott Global Point of Care offers i-STAT CHEM8+ Cartridge, CHOLESTECH LDXâ„¢ Analyzer, Afinionâ„¢ 2, and Panbioâ„¢ COVID-19 Antigen Self-Test.

Abbott Global Point of Care has made 12 acquisitions, including Binax, CanAm Care, and Cholestech.

Abbott Global Point of Care has 1 investor. Key investors include European Union.

Abbott Global Point of Care operates through Abbott Rapid Diagnostics A/S.

The website of Abbott Global Point of Care receives about 622 thousand visits a month and ranks #198,021 among all websites worldwide.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available